Innovation Crossroads: Tech, Business, and Global Impact

New 2025 data reveals an AI platform is slashing costs, improving chronic disease outcomes, and closing health equity gaps for hundreds of clinicians.

As McGraw Hill execs prep for a key investor conference, all eyes are on their digital-first strategy and how they'll navigate the AI-driven EdTech boom.

Biomea Fusion launches a high-stakes 2026 plan, advancing a novel diabetes drug to restore insulin cells and an oral pill to rival obesity giants.

TriSalus Life Sciences reports record 53% annual revenue growth, but a closer look reveals a complex financial picture for the oncology innovator.

The pediatric device firm posted 15% growth to $236.1M in 2025, issuing strong 2026 guidance fueled by its specialty bracing and European expansion.

National fencer Saif Nordin partners with Dr.stretch, bringing elite athletic recovery to the public to combat a national mobility issue costing millions.

At CES 2026, Chinese robotics firm RoboCT unveiled a bold strategy to turn exoskeletons from medical aids into everyday 'new organs' for all.

A new AI assistant, trained only on US financial regulations, aims to revolutionize compliance for banks by promising speed, security, and affordability.

Nominated for a top OCBJ award, Marla Noel’s journey from founder to growth advisor reveals a blueprint for 'drama free' success in business and community.

All four founding partners of SBSB Eastham have been named to the prestigious 2026 Lawdragon 500, a rare feat underscoring their firm's dominance.

With final approval for its C$3.3 billion acquisition by GTCR, Dentalcorp's move to private ownership is set to reshape Canada's dental landscape.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

With new funding and a veteran biotech leader, Montreal's Find Therapeutics advances its first-in-class therapy aimed at reversing nerve damage in MS.

Brookfield Asset Management renews its major share buyback plan, a strategic signal of confidence aimed at boosting shareholder value amid market shifts.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

At CES 2026, an awards ceremony marks two decades of upheaval, chronicling China's rise from follower to leader in the global electronics industry.

As stronger, cheaper vapes fuel a youth addiction crisis, a new initiative reframes relapse and offers digital tools to help Gen Z finally break free.

At CES 2026, Hitachi unveiled major AI alliances with NVIDIA and Google, betting its HMAX platform can embed intelligence into the world's core systems.

At CES 2026, LumiMind's BCI tech promises to guide you to sleep and power thought-controlled games, raising major scientific and ethical questions.

CES 2026: A new platform, Liquid Canvas, aims to liberate digital art from brand-locked TVs, offering a universal subscription for any screen.